Cardiovascular disease continues to be a dominant cause of morbidity and mortality in the United States and throughout much of the world. Advances that have been made in recent decades have come from the dedication and talents of many researchers working at the basic science level up through to clinical translation including population and care delivery studies. Over the past 35 years, The Johns Hopkins T32 Program in Cardiovascular Disease has trained many of these researchers, and with this renewal proposal we aim to continue this success. Our philosophy is to provide a broad-based, multi- and inter-disciplinary research environment with which to train post-doctoral fellows in basic, translational, clinical, and/or population science. Our program accepts physicians in Cardiology, some with PhDs as well, who are dedicated to pursuing an academic research career, and non-clinical fellows (PhD or MD) who are pursuing cardiovascular research. This mixture of basic and clinical scientists has fostered an unusual environment conducive to out-of-the-box thinking and translation of novel approaches to new understandings and treatment of cardiovascular disease. Most mentors have their primary appointments in the Division of Cardiology, but our faculty also include members from Pulmonary Medicine, Radiology, Institutes of Genetic Medicine and Cell Engineering, Biomedical Engineering, Pediatric Cardiology, Pathology, Epidemiology, and The Welch Center of Clinical Research. All of the faculty have long- standing histories of collaborations. Ten primary areas of research are covered: basic science in ventricular and vascular pathobiology, molecular biology and genetics, proteomics, cardiovascular imaging and computational modeling, epidemiology, risk assessment, genome-wide association research, preventive medicine strategies, clinical/translational studies in electrophysiology, coronary disease, and heart failure, and cardiovascular aging. The program supports 12 positions (our last renewal was approved for 13 positions) for 2 years of un-interrupted research training. It also includes a position with a 3rd structured year of formal course work to provide a masters degree in clinical investigation. With this renewal, we continue our primary goal of providing leadership in academic cardiology, training future leaders in all levels of research to help combat cardiovascular disease.
Heart and vascular disease is a leading cause of disability and death in the United States. The Johns Hopkins Cardiology Post-doctoral Training Program, now in its 35th consecutive year, provides broad multi-disciplinary training spanning from basic science up through to population/outcomes research. Our goal is to train the next generation of academic cardiovascular research leaders to continue the important work of tackling these important and common diseases.
|Hsu, Steven; Kambhampati, Swetha; Sciortino, Christopher M et al. (2018) Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock. Am Heart J 199:181-191|
|Hsu, Steven; Kokkonen-Simon, Kristen M; Kirk, Jonathan A et al. (2018) Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension. Circulation 137:2360-2370|
|Metkus, Thomas S; Guallar, Eliseo; Sokoll, Lori et al. (2018) Progressive myocardial injury is associated with mortality in the acute respiratory distress syndrome. J Crit Care 48:26-31|
|Aronis, Konstantinos N; Berger, Ronald D; Calkins, Hugh et al. (2018) Is human atrial fibrillation stochastic or deterministic?-Insights from missing ordinal patterns and causal entropy-complexity plane analysis. Chaos 28:063130|
|Lin, Brian Leei; Li, Amy; Mun, Ji Young et al. (2018) Skeletal myosin binding protein-C isoforms regulate thin filament activity in a Ca2+-dependent manner. Sci Rep 8:2604|
|Aronis, Konstantinos N; Ashikaga, Hiroshi (2018) Impact of number of co-existing rotors and inter-electrode distance on accuracy of rotor localization. J Electrocardiol 51:82-91|
|Ren, Xianfeng; Schmidt, William; Huang, Yiyuan et al. (2018) Fropofol decreases force development in cardiac muscle. FASEB J 32:4203-4213|
|Nakamura, Taishi; Zhu, Guangshuo; Ranek, Mark J et al. (2018) Prevention of PKG-1? Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation. Circ Heart Fail 11:e004740|
|Hashimoto, Toru; Kim, Grace E; Tunin, Richard S et al. (2018) Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition. Circulation 138:1974-1987|
|Blice-Baum, Anna C; Zambon, Alexander C; Kaushik, Gaurav et al. (2017) Modest overexpression of FOXO maintains cardiac proteostasis and ameliorates age-associated functional decline. Aging Cell 16:93-103|
Showing the most recent 10 out of 184 publications